Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2LSW

Structure, sulfatide-binding properties, and inhibition of platelet aggregation by a Disabled-2-derived peptide

2LSW の概要
エントリーDOI10.2210/pdb2lsw/pdb
NMR情報BMRB: 18449
分子名称Disabled homolog 2 (1 entity in total)
機能のキーワードplatelet aggregation inhibitor, sulfatides, dodecylphosphocholine, blood clotting
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm: P98082
タンパク質・核酸の鎖数1
化学式量合計4405.16
構造登録者
Xiao, S. (登録日: 2012-05-08, 公開日: 2012-09-19, 最終更新日: 2024-05-15)
主引用文献Xiao, S.,Charonko, J.J.,Fu, X.,Salmanzadeh, A.,Davalos, R.V.,Vlachos, P.P.,Finkielstein, C.V.,Capelluto, D.G.
Structure, Sulfatide Binding Properties, and Inhibition of Platelet Aggregation by a Disabled-2 Protein-derived Peptide.
J.Biol.Chem., 287:37691-37702, 2012
Cited by
PubMed Abstract: Disabled-2 (Dab2) targets membranes and triggers a wide range of biological events, including endocytosis and platelet aggregation. Dab2, through its phosphotyrosine-binding (PTB) domain, inhibits platelet aggregation by competing with fibrinogen for α(IIb)β(3) integrin receptor binding. We have recently shown that the N-terminal region, including the PTB domain (N-PTB), drives Dab2 to the platelet membrane surface by binding to sulfatides through two sulfatide-binding motifs, modulating the extent of platelet aggregation. The three-dimensional structure of a Dab2-derived peptide encompassing the sulfatide-binding motifs has been determined in dodecylphosphocholine micelles using NMR spectroscopy. Dab2 sulfatide-binding motif contains two helices when embedded in micelles, reversibly binds to sulfatides with moderate affinity, lies parallel to the micelle surface, and when added to a platelet mixture, reduces the number and size of sulfatide-induced aggregates. Overall, our findings identify and structurally characterize a minimal region in Dab2 that modulates platelet homotypic interactions, all of which provide the foundation for rational design of a new generation of anti-aggregatory low-molecular mass molecules for therapeutic purposes.
PubMed: 22977233
DOI: 10.1074/jbc.M112.385609
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 2lsw
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon